FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ketoprofen Capsules
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction; Rheumatology

Expand all

Teva Pharmaceuticals (Revised 06/13/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
50 mg Immediate-Release Capsules, bottle of 100 (NDC 0093-3193-01) 06/13/2018 Marketed by Teva Pharmaceuticals USA, Inc. The discontinuation of these products is a business decision.
75 mg Immediate-Release Capsules, bottle of 100 (NDC 0093-3195-01) 06/13/2018 Marketed by Teva Pharmaceuticals USA, Inc. The discontinuation of these products is a business decision.
75 mg Immediate-Release Capsules, bottle of 500 (NDC 0093-3195-05) 06/13/2018 Marketed by Teva Pharmaceuticals USA, Inc. The discontinuation of these products is a business decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English